@prefix prodottidellaricerca: . @prefix istituto: . @prefix prodotto: . istituto:CDS045 prodottidellaricerca:prodotto prodotto:ID172691 . istituto:CDS029 prodottidellaricerca:prodotto prodotto:ID172691 . @prefix pubblicazioni: . @prefix unitaDiPersonaleInterno: . unitaDiPersonaleInterno:MATRICOLA8491 pubblicazioni:autoreCNRDi prodotto:ID172691 . unitaDiPersonaleInterno:MATRICOLA20107 pubblicazioni:autoreCNRDi prodotto:ID172691 . istituto:CDS035 prodottidellaricerca:prodotto prodotto:ID172691 . @prefix unitaDiPersonaleEsterno: . unitaDiPersonaleEsterno:ID12515 pubblicazioni:autoreCNRDi prodotto:ID172691 . @prefix modulo: . modulo:ID2696 prodottidellaricerca:prodotto prodotto:ID172691 . modulo:ID2507 prodottidellaricerca:prodotto prodotto:ID172691 . @prefix rdf: . prodotto:ID172691 rdf:type prodotto:TIPO1302 . @prefix retescientifica: . prodotto:ID172691 rdf:type retescientifica:ProdottoDellaRicerca . @prefix rdfs: . prodotto:ID172691 rdfs:label "A minimal model of glucose absorption, production and disappearance for double-tracer oral glucose tolerance tests (Abstract/Poster in atti di convegno)"@en . @prefix xsd: . prodotto:ID172691 pubblicazioni:anno "2007-01-01T00:00:00+01:00"^^xsd:gYear . @prefix skos: . prodotto:ID172691 skos:altLabel "
Thomaseth K.; Pavan A.; Berria R.; Glass L.; Defronzo R. A.; Gastaldelli A. (2007)
A minimal model of glucose absorption, production and disappearance for double-tracer oral glucose tolerance tests
in Annual Meeting of American Diabetes Association, Chicago, 22-26 giugno 2007
"^^rdf:HTML ; pubblicazioni:autori "Thomaseth K.; Pavan A.; Berria R.; Glass L.; Defronzo R. A.; Gastaldelli A."^^xsd:string ; pubblicazioni:paginaInizio "A406"^^xsd:string ; pubblicazioni:altreInformazioni "Assessment of glucose absorption (GA), endogenous production (EGP) and disposal (GD) during OGTT requires co-administration of multiple-traced glucose via oral and iv routes as well as complex numerical data analysis. GA and EGP are commonly described by piecewise polynomials, which makes identification of covariates influencing these processes difficult. To overcome this problem, we propose a new mathematical modeling approach that expresses with simple parametric functions GA, EGP and GD, accounting also for effective hepatic and peripheral insulin. A population parameter estimation approach provided individual and average kinetic parameters as well as significant covariates (e.g. diabetes, BMI) that predict between-subject variability. Twelve type 2 diabetic patients (D) (5F/7M, age = 53.6\u00B12.5 yrs, BW = 81.9\u00B13.6 kg, BMI= 30.5\u00B11.1 kg m-2) and 10 normal glucose tolerant subjects (N) matched for BMI (5F/5M, age = 39.6\u00B13.7, BW = 90.1\u00B13.9, BMI = 31.1\u00B10.9), received after overnight fast a primed-continuous infusion of 0.25 \u00B5Ci/min [3-3H]-glucose and, after equilibration at T=0, a 75 g glucose OGTT with 75 \u00B5Ci [1-14C]-glucose added. Blood was sampled every 15 min between -30 and 240 min for measuring glucose and insulin. Insulin-independent glucose clearance was on average 0.72 dl/min (\u00B114% CV) and not correlated with any covariate; insulin sensitivity of glucose disappearance in N was 0.088 dl/min/(\u00B5U/ml) (\u00B119%) about 3 times that in D: 0.030 (\u00B120%); 50% inhibition of EGP was found at a small supra-basal insulin level 5.6 \u00B5U/ml (\u00B128%) which increased significantly with BMI +26%/(kg/m2) (\u00B18%) but not with diabetes. In addition to confirmatory findings and the new hypothesis about the dominant role of BMI on EGP, the presented population model characterizes in single individuals glucose kinetics from double-tracer OGTT and predicts the influence of covariates, which will allow the design of simplified experiments for routine use."^^xsd:string ; pubblicazioni:numeroVolume "56"^^xsd:string . @prefix ns12: . prodotto:ID172691 pubblicazioni:rivista ns12:ID293517 ; pubblicazioni:note "In: Annual Meeting of American Diabetes Association (Chicago, 22-26 giugno 2007). Proceedings, pp. A406 - A406. American Diabetes Association, 2007. Diabetes, 56, A406"^^xsd:string ; pubblicazioni:pagineTotali "1"^^xsd:string ; pubblicazioni:descrizioneSinteticaDelProdotto "Assessment of glucose absorption (GA), endogenous production (EGP) and disposal (GD) during OGTT requires co-administration of multiple-traced glucose via oral and iv routes as well as complex numerical data analysis. GA and EGP are commonly described by piecewise polynomials, which makes identification of covariates influencing these processes difficult. To overcome this problem, we propose a new mathematical modeling approach that expresses with simple parametric functions GA, EGP and GD, accounting also for effective hepatic and peripheral insulin. A population parameter estimation approach provided individual and average kinetic parameters as well as significant covariates (e.g. diabetes, BMI) that predict between-subject variability. Twelve type 2 diabetic patients (D) (5F/7M, age = 53.6\u00B12.5 yrs, BW = 81.9\u00B13.6 kg, BMI= 30.5\u00B11.1 kg m-2) and 10 normal glucose tolerant subjects (N) matched for BMI (5F/5M, age = 39.6\u00B13.7, BW = 90.1\u00B13.9, BMI = 31.1\u00B10.9), received after overnight fast a primed-continuous infusion of 0.25 \u00B5Ci/min [3-3H]-glucose and, after equilibration at T=0, a 75 g glucose OGTT with 75 \u00B5Ci [1-14C]-glucose added. Blood was sampled every 15 min between -30 and 240 min for measuring glucose and insulin. Insulin-independent glucose clearance was on average 0.72 dl/min (\u00B114% CV) and not correlated with any covariate; insulin sensitivity of glucose disappearance in N was 0.088 dl/min/(\u00B5U/ml) (\u00B119%) about 3 times that in D: 0.030 (\u00B120%); 50% inhibition of EGP was found at a small supra-basal insulin level 5.6 \u00B5U/ml (\u00B128%) which increased significantly with BMI +26%/(kg/m2) (\u00B18%) but not with diabetes. In addition to confirmatory findings and the new hypothesis about the dominant role of BMI on EGP, the presented population model characterizes in single individuals glucose kinetics from double-tracer OGTT and predicts the influence of covariates, which will allow the design of simplified experiments for routine use."^^xsd:string ; skos:note "Abstract"^^xsd:string ; pubblicazioni:affiliazioni "1, 2: ISIB-CNR;\n6: IFC - Istituto di fisiologia clinica CNR, Pisa, Italia"^^xsd:string ; pubblicazioni:titolo "A minimal model of glucose absorption, production and disappearance for double-tracer oral glucose tolerance tests"^^xsd:string ; prodottidellaricerca:prodottoDi modulo:ID2696 , istituto:CDS045 , istituto:CDS029 , modulo:ID2507 , istituto:CDS035 ; pubblicazioni:autoreCNR unitaDiPersonaleInterno:MATRICOLA20107 , unitaDiPersonaleInterno:MATRICOLA8491 , unitaDiPersonaleEsterno:ID12515 . @prefix parolechiave: . prodotto:ID172691 parolechiave:insiemeDiParoleChiave . ns12:ID293517 pubblicazioni:rivistaDi prodotto:ID172691 . parolechiave:insiemeDiParoleChiaveDi prodotto:ID172691 .